Literature DB >> 16874753

Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins.

Dominique Caparros-Lefebvre1, John Steele, Yaichiro Kotake, Shigeru Ohta.   

Abstract

Over the last 60 years an abnormally high prevalence of atypical Parkinsonism has been reported in 5 different geographic isolates. It was first described on Guam, later in New Guinea and in the Kii peninsula, on Guadeloupe, and in New Caledonia. We investigated the phenotype of atypical Parkinsonism in three of these foci and observed several similarities with dementia in most and amyotrophic lateral sclerosis in some. This disappearance of this disease in two places--Guam and New Guinea--suggested an environmental origin which has not been clarified before the disease ended. The exposure to annonaceae acetogenins and/or rotenone has been documented in four of these places, and experimental studies in animals demonstrated annonaceae acetogenins neurotoxicity, which is similar to rotenone neurotoxicity. Simultaneous exposure to acetogenins and rotenone could produce a synergistic toxicity on neurons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16874753     DOI: 10.1002/mds.21024

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

Review 1.  Traditional Uses, Phytochemistry and Pharmacological Activities of Annonacae.

Authors:  Bassam S M Al Kazman; Joanna E Harnett; Jane R Hanrahan
Journal:  Molecules       Date:  2022-05-27       Impact factor: 4.927

Review 2.  Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?

Authors:  Christopher A Shaw; Günter U Höglinger
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

Review 3.  Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.

Authors:  A C Ludolph; J Kassubek; B G Landwehrmeyer; E Mandelkow; E-M Mandelkow; D J Burn; D Caparros-Lefebvre; K A Frey; J G de Yebenes; T Gasser; P Heutink; G Höglinger; Z Jamrozik; K A Jellinger; A Kazantsev; H Kretzschmar; A E Lang; I Litvan; J J Lucas; P L McGeer; S Melquist; W Oertel; M Otto; D Paviour; T Reum; A Saint-Raymond; J C Steele; M Tolnay; H Tumani; J C van Swieten; M T Vanier; J-P Vonsattel; S Wagner; Z K Wszolek
Journal:  Eur J Neurol       Date:  2009-03       Impact factor: 6.089

4.  The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features.

Authors:  Eleanna Kara; Helen Ling; Alan M Pittman; Karen Shaw; Rohan de Silva; Roberto Simone; Janice L Holton; Jason D Warren; Jonathan D Rohrer; Georgia Xiromerisiou; Andrew Lees; John Hardy; Henry Houlden; Tamas Revesz
Journal:  Neurobiol Aging       Date:  2012-05-16       Impact factor: 4.673

5.  Squamocin modulates histone H3 phosphorylation levels and induces G1 phase arrest and apoptosis in cancer cells.

Authors:  Chien-Chih Lee; Yi-Hsiung Lin; Wen-Hsin Chang; Pei-Chin Lin; Yang-Chang Wu; Jan-Gowth Chang
Journal:  BMC Cancer       Date:  2011-02-08       Impact factor: 4.430

6.  Hypothesis: Etiologic and Molecular Mechanistic Leads for Sporadic Neurodegenerative Diseases Based on Experience With Western Pacific ALS/PDC.

Authors:  Peter S Spencer
Journal:  Front Neurol       Date:  2019-07-31       Impact factor: 4.003

Review 7.  The Diversity of Cyanobacterial Toxins on Structural Characterization, Distribution and Identification: A Systematic Review.

Authors:  Xingde Du; Haohao Liu; Le Yuan; Yueqin Wang; Ya Ma; Rui Wang; Xinghai Chen; Michael D Losiewicz; Hongxiang Guo; Huizhen Zhang
Journal:  Toxins (Basel)       Date:  2019-09-12       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.